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Background and objective: Major risk factors for congestive heart failure (CHF) are myocardial infarction,
hypertension, diabetes, atrial ﬁbrillation, smoking, left ventricular hypertrophy (LVH) and obesity.
However, since these risk factors only explain part of the risk of CHF, we investigated whether persistent
organic pollutants (POPs) might also play a role.
Methods: In the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study, left
ventricular ejection fraction, (EF), E/A-ratio and isovolumic relaxation time (IVRT), were determined by
echocardiography and serum samples of 21 POPs were analyzed in serum measured by high-resolution
chromatography coupled to high-resolution mass spectrometry (HRGC/HRMS) in 998 subjects all aged
70 years.
Results: In this cross-sectional analysis, high levels of several of the polychlorinated biphenyls (PCB
congeners 99, 118, 105, 138, 153, and 180) and octachlorodibenzo-p-dioxin (OCDD) were signiﬁcantly
related to a decreased EF. Some POPs were also related to a decreased E/A-ratio (PCBs 206 and 209). All
the results were adjusted for gender, hypertension, diabetes, smoking, LVH and BMI, and subjects with
myocardial infarction or atrial ﬁbrillation were excluded from the analysis.
Conclusions: Circulating levels of POPs were related to impairments in both left ventricular systolic and
diastolic function independently of major congestive heart failure risk factors, suggesting a possible role
of POPs in heart failure.
& 2013 Elsevier Inc. Open access under CC BY-NC-ND license.1. Introduction
Congestive heart failure (CHF) is a major cardiovascular dis-
ease associated with poor long-term prognosis, decreased life
quality and high risk of hospitalization.
Hypertension and ischemic heart disease are the most power-
ful known risk factors for CHF in elderly patients (Levy et al.,
1996). Atrial ﬁbrillation is also an independent risk factor for
congestive heart failure (Maisel and Stevenson, 2003), as well as
diabetes, smoking, left ventricular hypertrophy (LVH) and obesityE, Bromated diphenyl ether;
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-ND license.(Eriksson et al., 1989; Ho et al., 1993). However, as these established
risk factors can only explain part of the risk of CHF, other factors
might be of importance.
Measurable levels of persistent organic pollutants (POP) have
been reported in humans for several decades. In recent years, data
on associations between elevated circulating levels of POPs and a
number of CHF risk factors, such as hypertension, obesity, and
diabetes, as well as metabolic syndrome have been established
(Everett et al., 2011; Lee et al., 2007, 2012, 2011; Ronn et al.,
2011). Furthermore, prevalent myocardial infarction has also
been found to associate with elevated levels of certain POPs
including dioxins and PCBs (Dalton et al., 2001; Flesch-Janys
et al., 1995; Ha et al., 2007; Sergeev and Carpenter, 2005).
Animal studies indicate that environmental pollutants, such as
dioxins, hexachlorobenzene (HCB) and polychlorinated biphenyls
(PCB 126) increase heart weight and induce hypertension (Arnold
et al., 1986; Kopf et al., 2008; Lind et al., 2004). We hypothesize
that certain POPs inﬂuence the left ventricular (LV) systolic and
diastolic function. To test this hypothesis, we used the population-
based Prospective Investigation of the Vasculature in Uppsala
Seniors (PIVUS) study (Lind et al., 2005), in which echocardiographic
Table 1
Basic characteristics and major cardiovascular risk factors in the total PIVUS
Y.S. Lind et al. / Environmental Research 123 (2013) 39–4540data on LV systolic and diastolic function and circulating POP levels
in almost 1,000 subjects have been measured.cohort. Means are given7SD. BMI¼body mass index. SBP¼systolic blood pres-
sure. DBP¼diastolic blood pressure.
Mean PIVUS cohort
N 998
Female (%) 50.2
Height (cm) 16979.1
Waist circumferences (cm) 91712
BMI (kg/m2) 27.074.3
Waist/hip ratio 0.970.075
SBP (mmHg) 150723
DBP (mmHg) 79710
Heart rate (beats/min) 6278.7
Serum cholesterol (mmol/l) 5.471.0
LDL-cholesterol (mmol/l) 3.370.88
HDL-cholesterol (mmol/l) 1.570.42
Serum triglycerides (mmol/l) 1.370.60
Fasting blood glucose (mmol/l) 5.371.6
Current smoking (%) 11
Diabetes (%) 11
Myocardial infarction (%) 7
Congestive heart failure (%) 4
Atrial ﬁbrillation (%) 3
Left ventricular hypertrophy (%) 36
Ejection fraction (%) 65710
E/A ratio 0.9670.28
Isovolumic relaxation time (ms) 121721
Table 2
Distribution of serum concentrations (ng/g lipid) by med-
ian and 25th and 75th percentile of individual persistent
organic pollutants. (n¼988).
Variable Median (25th and 75th percentile)
PCB 74 13.9 (10; 18.8)
PCB 99 13.8 (9.5; 19.4)
PCB 105 4.9 (3.3; 7.0)
PCB 118 30 (21.6; 41.7)
PCB 126 6.2 (3.3; 10.8)
PCB 138 124.9 (95.3; 168.2)
PCB 153 217 (166.8; 279.8)
PCB 156 23.6 (18.2; 29.9)
PCB 157 4.3 (3.2; 5.5)
PCB 169 26 (20.1; 34.2)
PCB 170 74.8 (59.6; 96.3)
PCB 180 176.3 (139.3; 229)
PCB 189 2.9 (2.2; 3.9)
PCB 194 18.4 (13.6; 24.3)
PCB 206 4.2 (3.1; 5.4)
PCB 209 4.1 (3; 5.3)
OCDD 0.4 (0.2; 0.6)
HCB 38 (29; 50.2)
TNC 20.8 (14.1; 31.6)
p,p’–DDE 290.6 (158.1; 538.4)
BDE 47 1.9 (1.5; 2.9)
PCB¼polychlorinated biphenyls, OCDD¼octachlorodibenzo-
p-dioxin, HCB¼hexachlorobenzene, TNC¼trans-nonachlor,
p,p0-DDE¼2,2-bis(4-chlorophenyl)-1,1-dichloroethene,
BDE¼bromodiphenyl ether.2. Material and methods
2.1. Subjects
Eligible for the study were all subjects aged 70 living in the community of
Uppsala, Sweden. The subjects were chosen from the register of community
residents in a randomized order, and were invited in a randomized order April
2001 to June 2004 (Lind et al., 2005). The subjects received an invitation by letter
within two months of their 70th birthday. The PIVUS study aimed to investigate
an elderly population standardized to the age of 70, since age is such an important
characteristic, especially in the elderly. Of the 2025 subjects invited, 1016 subjects
participated, yielding a participation rate of 50.1%. The study was approved by the
Ethics Committee of the Uppsala University, and the participants gave their
informed consent.
Subjects with myocardial infarction that had been treated in hospital were
excluded. So, too, were those with atrial ﬁbrillation.
Approximately 10% of the cohort reported a history of coronary heart disease; 4%
reported stroke, 3.8% congestive heart failure, and 9% diabetes mellitus. Almost half
the cohort reported any cardiovascular medication (45%), with antihypertensive
medication being the most prevalent (32%). Fifteen percent reported use of statins,
while insulin and oral antiglycemic drugs were reported in 2 and 6%, respectively.
As the participation rate in this cohort was only 50%, we carried out an
evaluation of cardiovascular disorders and medications in 100 consecutive non-
participants. The prevalences of cardiovascular drug intake, history of myocardial
infarction, coronary revascularization, antihypertensive medication, statin use and
insulin treatment were similar to those in the investigated sample, while the
prevalences of diabetes (17%), congestive heart failure (6.9%) and stroke (6.7%)
tended to be higher among the non-participants.
2.2. Basic investigation
Before the examination the participants were asked to ﬁll in a questionnaire
about their medical history, smoking habits, and regular medication. All subjects
were investigated in the morning after fasting since midnight, thus with a fasting
period of at least eight hours. No medication or smoking was allowed after
midnight. Blood pressure was measured by a calibrated mercury sphygmoman-
ometer to nearest mm Hg after at least 30 min of rest, and the average of three
recordings was used. Lipid variables and fasting blood glucose were measured by
standard laboratory techniques. Diabetes was deﬁned as fasting plasma glucose
Z7.0 mmol/l or antidiabetic treatment. Smoking was deﬁned as current smoking;
all basic characteristics are given in Table 1.
2.3. Echocardiography
A comprehensive two-dimensional and Doppler echocardiography was per-
formed with an Acuson XP124 cardiac ultrasound unit (Acuson, California, USA) A
2.5 MHz transducer was used for the majority of the examinations. Presence of
stenosis or regurgitations in the mitral and aortic valves was recorded by use of
color and continuous Doppler.
LV ejection fraction (EF) was visually assessed from examinations from the
parasternal and apical projections. The transmitral Dopper amplitudes of the E and
Awaves were assessed in the apical projection and the E/A-ratio was calculated. The
isovolumetric relaxation time (IVRT) was measured by Doppler in the apical view as
the time between the closure of the aortic valve (end of blood ﬂow through the
valve) and the opening of the mitral valve. LV mass was determined from M-mode
recordings from the parasternal view using the Penn convention and was indexed
for height2.7. The cut-off limit for LVH was 51 g/m2.7 (Mureddu et al., 2001).
Subjects with valvular disease or cardiomyopathies were excluded from the
investigated sample (n¼23). Also subjects with signs of a possible restrictive
transmitral ﬁlling pattern (E/A-ratio 41.5 and IVRTo75 ms) were excluded from
the analysis (n¼7) regarding diastolic function.
2.4. POPs analyses
POPs were measured in stored serum samples collected at baseline. Analyses of
POPs were preformed using a Micromass Autospec Ultima (Waters, Milford, MA, USA)
high-resolution chromatography coupled to high-resolution mass spectrometry
(HRGC/HRMS). All details on POP analyses have been reported elsewhere (Salihovic
et al., 2012). A total of 23 POPs were measured: 16 polychlorinated biphenyls (PCBs),
ﬁve organochlorine (OC) pesticides, one octachlorodibenzo-p-dioxin (OCDD), and one
brominated biphenyl ether (BDE). Among the 23 POPs measured, two OC pesticides
(trans-chlordane and cis-chlordane) with detection rates o10% were not included in
the ﬁnal results/statistical analyses. An established summation formula based onserum cholesterol and serum triglyceride concentrations was used to calculate the total
amount of lipids in each plasma sample (Rylander et al., 2006). Thereafter the wet-
weight concentrations of the POPs were divided by this estimation of lipids to obtain
lipid-normalized values. See Table 2 for details.2.5. Statistics
All POPs levels and E/A ratios were log-transformed, to achieve normal
distributions. Since POP levels tend to differ between men and women, the ﬁrst
set of linear regression models between LV variables and POPs were adjusted for
gender only. Since no interactions between gender and POPs were found, no
Y.S. Lind et al. / Environmental Research 123 (2013) 39–45 41gender-speciﬁc analysis was performed. Interaction between the different POPs
and gender was evaluated by including an interaction term (POPngender) in the
statistical analysis (data not shown).
As a second step to deal with confounding, adjustments were also performed for
the classical risk factors for CHF, gender, blood pressure, antihypertensive treat-
ment, diabetes, smoking, LVH, and BMI. The occurrence of potential non-linear
relationships was evaluated by multiple fractional polynomial regression analysis.
The statistical program package STATA 11 (College Station, TX, USA) was used.3. Results
3.1. POPs vs. LV systolic function
When relating the POP levels to LV EF, seven out of the PCBs
(congeners 74, 99, 105, 118, 138, 153, 180), four of the pesticides
(HCB, TNC, and p,p0-DDE), and OCCD were signiﬁcantly associated
with a decreased ejection fraction after adjustment for gender
only (po0.05–0.001, see Table 3 for details). Six of the PCBs
(congeners 99, 105, 118, 138, 153, 180) and OCDD were still
signiﬁcantly correlated after adjustment for multiple established
risk factors (gender, hypertension, diabetes, smoking, LVH and
obesity) (po0.05–0.001, see Table 3 for details).
A very similar picture emerges when the POP levels in those
with a reduced LV EF (o50%, 15.2% of the population) were
compared to those with a normal LV EF. Following adjustment for
the multiple risk factors, the levels of PCB74 (p¼0.01), PCB105
(p¼0.005), PCB118 (p¼0.0001), PCB126 (p¼0.01), PCB138
(p¼0.01), PCB153 (p¼0.01), PCB180 (p¼0.01), and OCDD
(p¼0.005) were all higher in those with a reduced LV EF.3.2. POPs vs. LV diastolic function
None of the POPs was signiﬁcantly related to the E/A ratio
when adjusted for gender only, but two of the higher chlorinated
PCBs (congeners 206 and 209) showed associations following the
multiple adjustment (po0.01, see Table 4 for details).Table 3
Linear multiple regression models relating different POPs to left ventricular ejection f
model. Model A is adjusted for gender only. Model B is adjusted for gender, smoki
ventricular hypertrophy at ultrasound. Subjects with myocardial infarction or atrial ﬁb
Variable Model A
Beta (95% CI) p-valu
PCB 74 1.216 (2.198; 0.235) 0.015
PCB 99 1.497 (2.343; 0.651) 0.000
PCB 105 1.465 (2.303; 0.627) 0.000
PCB 118 1.888 (2.813; 0.962) 0.000
PCB 126 0.157 (0.727; 0.413) 0.589
PCB 138 1.784 (2.862; 0.705) 0.001
PCB 153 1.905 (3.079; 0.732) 0.001
PCB 169 0.805 (1.909; 0.3) 0.153
PCB 156 0.968 (2.195; 0.258) 0.122
PCB 157 0.63 (1.755; 0.495) 0.272
PCB 170 1.173 (2.493; 0.148) 0.082
PCB 180 1.376 (2.678; 0.073) 0.038
PCB 189 0.591 (1.397; 0.216) 0.151
PCB 194 0.343 (1.007; 0.322) 0.312
PCB 206 0.637 (1.766; 0.493) 0.269
PCB 209 0.13 (0.882; 1.142) 0.801
OCDD 1.155 (1.99; 0.319) 0.006
HCB 1.207 (2.393;  0.02) 0.046
TNC 1.032 (1.909; 0.154) 0.021
p,p’–DDE 0.577 (1.111; 0.042) 0.034
BDE 47 0.112 (0.872; 0.648) 0.772
PCB¼polychlorinated biphenyls, OCDD¼octachlorodibenzo-p-dioxin, HCB¼hexachlor
oethene, BDE¼bromodiphenyl ether.A very similar picture emerges when we divide the sample
according to whether the E/A-ratio is above or below 1.0, as a sign
of LV diastolic dysfunction. High levels of PCB congeners 206 and
209 were then related to LV diastolic dysfunction (OR 1.52 using
ln-transformed values for the PCBs, 95%CI 1.09–2.13, p-value
0.012 for PCB206, and OR 1.42, 95%CI 1.06–1.93, p-value 0.021
for PCB206) following the multiple adjustment.
Only borderline signiﬁcant associations were found between
the POPs and IVRT (Table 5).
No signiﬁcant interactions were seen between POP levels and
gender regarding the relationships described above. Therefore,
gender was treated as a confounder, and the analysis was not
stratiﬁed according to gender. Using multiple fractional polyno-
mial regression analysis to screen for possible non-linear relation-
ships, only the relationship between PCB105 and the E/A-ratio
was non-linear with a signiﬁcant squared term (p¼0.004) giving
a U-shaped form of the relationship. However, this relationship
was not signiﬁcant following adjustment for multiple risk factors.4. Discussion
Several of the POPs were related signiﬁcantly to a decreased LV
EF even following adjustment for established risk factors for CHF
following exclusion of subjects with myocardial infarction, valv-
ular disease or atrial ﬁbrillation, suggesting that POPs might play
a role in LV systolic dysfunction that is not mediated by the
traditional risk factors. Some of the POPs were also related to LV
diastolic function.
To the best of our knowledge, no other study has investigated
whether POPs are related to LV function or to clinically manifest
CHF. Several studies have reported associations between POP levels
and risk factors for CHF, such as hypertension, diabetes and obesity
(Everett et al., 2011; Lee et al., 2007, 2012, 2011; Ronn et al., 2011),
but all of these factors were adjusted for in the analysis.raction. The regression coefﬁcient (beta, and 95% CI) is given for each regression
ng, systolic blood pressure, antihypertensive medication, BMI, diabetes and left
rillation were excluded from the analysis.
Model B
e Beta (95% CI) p-value
4 0.874 (1.862; 0.113) 0.0830
5 1.169 (2.031; 0.307) 0.0080
6 1.139 (2.009; 0.269) 0.0105
1 1.636 (2.598; 0.674) 0.0009
4 0.086 (0.665; 0.492) 0.7701
2 1.372 (2.469; 0.274) 0.0145
5 1.684 (2.895; 0.473) 0.0065
9 0.946 (2.058; 0.167) 0.0960
0 0.971 (2.215; 0.273) 0.1263
5 0.667 (1.804; 0.47) 0.2504
1 1.281 (2.637; 0.076) 0.0646
7 1.623 (2.971; 0.275) 0.0185
3 0.805 (1.607; 0.002) 0.0496
4 0.544 (1.214; 0.125) 0.1115
5 0.934 (2.097; 0.23) 0.1161
4 0.223 (1.278; 0.831) 0.6782
9 1.208 (2.045; 0.371) 0.0048
6 0.74 (1.938; 0.458) 0.2263
4 0.676 (1.568; 0.216) 0.1381
7 0.258 (0.806; 0.291) 0.3577
7 0.151 (-0.903; 0.6) 0.6933
obenzene, TNC¼trans-nonachlor, p,p0-DDE¼2,2-bis(4-chlorophenyl)-1,1-dichlor-
Table 4
Linear multiple regression models relating different POPs to E/A-ratio. The regression coefﬁcient (b, and 95% CI) is given for each regression model. Model A is adjusted for
gender only. Model B is adjusted for gender, smoking, systolic blood pressure, antihypertensive medication, BMI, diabetes and left ventricular hypertrophy at ultrasound.
Subjects with myocardial infarction or atrial ﬁbrillation were excluded from the analysis.
Variable Model A Model B
Beta (95% CI) p-value b (95% CI) p-value
PCB 74 0.017 (0.051; 0.016) 0.3128 0.006 (0.04; 0.029) 0.7433
PCB 99 0.01 (0.039; 0.019) 0.4926 0.001 (0.029; 0.031) 0.9439
PCB 105 0.023 (0.052; 0.006) 0.1261 0.002 (0.033; 0.028) 0.8770
PCB 118 0.022 (0.054; 0.01) 0.1855 0.003 (0.037; 0.031) 0.8728
PCB 126 0.003 (0.016; 0.022) 0.7539 0.006 (0.026; 0.014) 0.5862
PCB 138 0.022 (0.059; 0.016) 0.2573 0.011 (0.05; 0.027) 0.5637
PCB 153 0.014 (0.054; 0.027) 0.5166 0.012 (0.055; 0.03) 0.5735
PCB 156 0.002 (0.044; 0.041) 0.9417 0.03 (0.073; 0.014) 0.1827
PCB 157 0.008 (0.031; 0.046) 0.6920 0.01 (0.05; 0.03) 0.6285
PCB 169 0.005 (0.032; 0.043) 0.7784 0.016 (0.055; 0.023) 0.4243
PCB 170 0.006 (0.052; 0.039) 0.7902 0.04 (0.087; 0.008) 0.0996
PCB 180 0.003 (0.048; 0.042) 0.9000 0.041 (0.089; 0.006) 0.0885
PCB 189 0.016 (0.012; 0.043) 0.2705 0.001 (0.029; 0.027) 0.9402
PCB 194 0.006 (0.017; 0.029) 0.6068 0.01 (0.033; 0.014) 0.4207
PCB 206 0.02 (0.058; 0.019) 0.3193 0.055 (0.096;  0.015) 0.0077
PCB 209 0.012 (0.047; 0.022) 0.4792 0.051 (0.088;  0.015) 0.0064
OCDD 0.001 (0.03; 0.028) 0.9288 0.0 (0.029; 0.029) 0.9928
HCB 0.038 (0.079; 0.002) 0.0661 0.032 (0.074; 0.009) 0.1300
TNC 0.008 (0.039; 0.022) 0.5812 0.009 (0.022; 0.04) 0.5573
p,p’–DDE 0.002 (0.02; 0.017) 0.8449 0.012 (0.007; 0.031) 0.2218
BDE 47 0.006 (0.031; 0.02) 0.6698 0.004 (0.03;0.022) 0.7452
PCB¼polychlorinated biphenyls, OCDD¼octachlorodibenzo-p-dioxin, HCB¼hexachlorobenzene, TNC¼trans-nonachlor, p,p0-DDE¼2,2-bis(4-chlorophenyl)-1,1-dichlor-
oethene, BDE¼bromodiphenyl ether.
Table 5
Linear multiple regression models relating different POPs to IVRT. The regression coefﬁcient (beta, and 95% CI) is given for each regression model. Models A is adjusted for
gender only. Models B is adjusted for gender, smoking, systolic blood pressure, antihypertensive medication, BMI, diabetes and left ventricular hypertrophy at ultrasound.
Subjects with myocardial infarction or atrial ﬁbrillation were excluded from the analysis.
Variable Model A Model B
Beta (95% CI) p-value Beta (95% CI) p-value
PCB 74 2.084 (0.657; 4.825) 0.1365 0.149 (2.328; 2.627) 0.9062
PCB 99 2.345 (0.013; 4.703) 0.0516 0.531 (1.615; 2.676) 0.6279
PCB 105 2.413 (0.053; 4.773) 0.0454 0.03 (2.215; 2.156) 0.9788
PCB 118 2.506 (0.11; 5.122) 0.0608 0.085 (2.514; 2.344) 0.9453
PCB 126 1.343 (2.916; 0.23) 0.0946 0.295 (1.735; 1.145) 0.6881
PCB 138 2.106 (0.909; 5.121) 0.1713 0.358 (2.383; 3.099) 0.7979
PCB 153 0.437 (2.923; 3.798) 0.7987 0.361 (3.399; 2.678) 0.8160
PCB 156 1.215 (4.72; 2.29) 0.4971 0.733 (2.496; 3.961) 0.6566
PCB 157 1.518 (4.616; 1.579) 0.3370 0.097 (2.926; 2.731) 0.9463
PCB 169 3.03 (6.087; 0.026) 0.0523 1.114 (3.898; 1.67) 0.4332
PCB 170 1.72 (5.377; 1.937) 0.3569 0.185 (3.213; 3.583) 0.9150
PCB 180 2.49 (6.105; 1.125) 0.1774 0.275 (3.663; 3.112) 0.8736
PCB 189 0.725 (3.026; 1.575) 0.5367 0.508 (1.583; 2.599) 0.6341
PCB 194 2.0 (3.806; 0.194) 0.0303 0.969 (2.614; 0.676) 0.2487
PCB 206 2.149 (5.254; 0.957) 0.1754 0.032 (2.872; 2.935) 0.9829
PCB 209 3.009 (5.792; 0.226) 0.0344 0.697 (3.331; 1.938) 0.6043
OCDD 0.061 (2.434; 2.312) 0.9598 0.477 (2.607; 1.654) 0.6612
HCB 3.66 (0.371; 6.95) 0.0295 3.187 (0.209; 6.166) 0.0363
TNC 1.213 (1.22; 3.646) 0.3290 0.136 (2.363; 2.091) 0.9048
p,p’–DDE 0.707 (0.808; 2.223) 0.3606 0.839 (2.219; 0.54) 0.2334
BDE 47 1.645 (0.461; 3.752) 0.1261 1.352 (0.517; 3.22) 0.1567
PCB¼polychlorinated biphenyls, OCDD¼octachlorodibenzo-p-dioxin, HCB¼hexachlorobenzene, TNC¼trans-nonachlor, p,p0-DDE¼2,2-bis(4-chlorophenyl)-1,1-dichlor-
oethene, BDE¼bromodiphenyl ether.
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In the present study it was mainly the PCBs with a low degree of
chlorination (PCB105 and PCB118) that together with OCDD showed
the closest relationships vs. a low EF. On the other hand, it was the
PCBs with the highest degree of chlorination that were related to a
poor E/A-ratio. Thus, from this perspective it could be suspected that
different PCBs might have different effects on the heart.PCBs are usually classiﬁed in dioxin-like and non-dioxin-like in
terms of their mode of action. However, the PCBs with the highest
afﬁnity to the acryl hydrocarbon receptor (AHR) measured in the
present study (PCB126 and PCB169) did not relate strongly to
either the EF or the E/A-ratio. PCB105 and PCB118 are dioxin-like
PCBS, but their effects on the AHR are weak (TEQ 0.0001). PCB206
and 209 are not dioxin-like, so in this case other mechanisms of
action must be involved both in their association vs. LV diastolic
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like PCBs could induce estrogen receptor responses by binding to
the estrogen receptor alpha (Li et al., 2012). It has also been
suggested that non-dioxin-like PCBs would inﬂuence dopamine
receptors (Lesmana et al., 2012), as well as inﬂuence the action of
glutathione S-transferases (GSTs) being responsible for detoxiﬁ-
cation by catalyzing the conjugation reaction of glutathione (GSH)
to xenobiotics (Tian et al., 2012).
Furthermore, non-dioxin-like PCBs enhance the activity of
ryanodine receptor (RyR) calcium ion (Ca(2þ)) channels, which
play a central role in regulating the dynamics of intracellular
Ca(2þ) signaling (Wayman et al., 2012). Thus, several mechan-
isms have been described whereby non-dioxin-like PCBs could
affect different organs, such as the myocardium. How this relates
to LV diastolic dysfunction is not well understood, however. A
main driver of LV diastolic dysfunction is increased wall thickness
mainly due to increased ﬁbrosis.
Most experimental studies on mechanisms for how POPs affect
different organ systems have focused on dioxin activity using the
potent dioxin TCDD as a model compound for dioxins Persistent
cardiac effects of dioxins have been noted in many species, such
as zebra ﬁshes, mice, and chicken (Puga, 2011). For example,
developmental exposure to TCDD resulted in dose-dependent
increase in pericardial effusion and circulatory failure in small
aquarium ﬁsh (Dong et al., 2010). Exposing adult, as well as fetal,
mice to TCDD led to cardiac hypertrophy and increased blood
pressure (Aragon et al., 2008; Kopf et al., 2008). Studies have also
shown that TCDD affects cardiac gene expression during devel-
opment in the murine heart in a manner that may increase the
susceptibility to cardiovascular dysfunction (Aragon et al., 2008;
Thackaberry et al., 2005).
The heart muscle is a highly oxidative tissue that produces
490% of its energy from mitochondrial respiration (Neubauer,
2007). One recent experimental study performed in cardiomyo-
cytes derived from embryonic mice stem cells showed that TCDD
down-regulated genes, several of which were involved in the
oxidative phosphorylation pathway. Furthermore, the arrange-
ment of mitochondria was altered, and ATP production was
reduced (Neri et al., 2011). Another experimental study (Ruzzin
et al., 2010) observed alterations in mitochondrial function and
oxidative capacity in the liver of rats exposed to a mixture of POPs
including dioxins and PCBs.
It has also been shown experimentally that POP exposure
induces oxidative stress (Kopf et al., 2008; Park et al., 1996;
Shertzer et al., 1998) and inﬂammation (Majkova et al., 2009;
Vogel et al., 2007), two putative players in the development of
myocyte dysfunction. This could also be a link between POP
exposure and LV dysfunction, since ROS and proinﬂammatory
cytokines could affect myocardial function (Guggilam et al., 2007;
Mellin et al., 2005) and have been found to be elevated in heartFig. 1. Potential mechanisms whereby persistent organic pollutants might affect
left ventricular function.failure patients or to predict future heart failure (Barac et al.,
2012; Ingelsson et al., 2005). Some of these potential pathophy-
siological mechanisms are summarized in Fig. 1.
However, when toxic equivalents (TEQ) were calculated in the
present sample as a marker of activation of the AHR due to the
POP exposure (Van den Berg et al., 1998; Van den Berg et al.,
2006) using PCB 105, 118, 126, 156, 157, 169, 189 and OCDD, no
associations with EF, E/A-ratio and IVRT were found (data not
shown).
4.2. POP levels
The median concentrations and the pattern of PCBs detected in
the current study are comparable to those observed in previous
studies from Sweden and Europe (Covaci et al., 2002; Koppen
et al., 2002; Weiss et al., 2006). When we extracted data from
1128 participants aged 70 years and older from the fourth report
of the United States National Health and Nutrition Exposure
Survey (NHANES 2003-2004) (http://www.cdc.gov/nchs/nhanes.
htm), we found PCB levels to be higher in the PIVUS sample, but
the organochlorine pesticide levels (HCB, TNC and DDE) to be
lower compared to the US sample. Thus, regional differences in
exposures to POPs do exist (Lampa et al., 2012).
4.3. Clinical implications
The present study suggests an association between POP
exposure and LV function in a population with a low prevalence
of overt heart failure. The clinical implication of this study is yet
unknown. The ﬁrst step forward to resolve this matter would be
to study POP levels in heart failure in case-control and prospec-
tive studies. The prevalence of overt heart failure in the present
study is unfortunately too low for a meaningful evaluation.
4.4. Multiple comparisons
Correction for multiple comparisons was not performed for
several reasons. First, this is an exploratory study. It is the ﬁrst
study of its kind about circulating levels of persistent organic
pollutants versus LV systolic and diastolic dysfunction in a large
population. Secondly, we have recently published a cluster analysis
in combination with a principal component analysis of the PCBs
(and also other environmental contaminants) (Lampa et al., 2012).
One of the major ﬁndings was that less chlorinated PCBs are closely
related, while a separate cluster was seen for the highly chlorinated
PCBs. Thus, based on these ﬁndings a strict Bonferroni adjustment
would not be appropriate. Schematically it appears that the highly
chlorinated PCBs (206 and 209) were related to the LV diastolic
function, while several of the lower chlorinated PCBs were asso-
ciated with LV systolic function. In such a case, calculation of the
sum of PCBs is not an informative way forward.
4.5. Limitations
As the present sample was limited to Caucasians aged 70,
caution should be observed in drawing conclusions regarding
other ethnic and age groups. Furthermore, the present study had a
moderate participation rate. In the present study outmoded
ultrasonographic equipment was used that did not allow for
modern measurements of LV EF. Therefore, rather than using
the Teicholtz formula for LV EF determinations, which we have
found inaccurate in the elderly that have very divergent shapes of
the LV (Andren et al., 1998) or the more modern biplanar or 3D
techniques, we estimated LV EF by visual inspection. This was
performed by the same observer throughout the study to whom
no other clinical or biochemical data was disclosed. Since visual
Y.S. Lind et al. / Environmental Research 123 (2013) 39–4544determinations of LV EF are inferior to modern ways to measure
LV EF, false negative results might be presented. However, it is
very unlikely that observed relationships between some of the
PCBs and LV EF (po0.001 for PCB118) are due to the fact that a
less modern way to determine LV EF was used. In fact, if superior
techniques had been used, it is likely that the observed relation-
ships would have been even stronger.
Using more modern techniques, such as tissue Doppler, it is
possible to categorize subjects into those with diastolic dysfunction
or not (Wu et al., 2012). Since we did not have such measurements,
we treated the E/A-ratio as a continuous variable in the primary
analysis following exclusion of subjects with a presumed restrictive
transmitral ﬁlling pattern. However, we cannot be sure that some
subjects with pseudo-normalization of the E/A-ratio might not have
been misclassiﬁed this way, although the numbers of such indivi-
duals are likely to be low in this cohort when subjects with
myocardial infarction have been removed. If misclassiﬁcation has
occurred, this will only lead to false negative ﬁndings and not induce
the relationships between the highly chlorinated PCBs and the
E/A-ration found in the present sample.
In conclusion, circulating levels of POPs were related to
impairments in both systolic and diastolic function independently
of major congestive heart failure risk factors, suggesting that is it
worthwhile to investigate the role of POPs in heart failure.Ethics
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